Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 1/2020

01-01-2020 | Letter to the Editor

Response to “Is grip strength an actual/significant predictor of areal bone mineral density by itself? Potential confounders and/or effect modifiers”

Authors: Takahiro Tachiki, Katsuyasu Kouda, Namiraa Dongmei, Junko Tamaki, Masayuki Iki, Jun Kitagawa, Naonobu Takahira, Yuho Sato, Etsuko Kajita, Yuki Fujita, Akiko Yura, Sadanobu Kagamimori

Published in: Journal of Bone and Mineral Metabolism | Issue 1/2020

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Tachiki T, Kouda K, Dongmei N, Tamaki J, Iki M, Kitagawa J, Takahira N, Sato Y, Kajita E, Fujita Y, Yura A, Kagamimori S (2019) Muscle strength is associated with bone health independently of muscle mass in postmenopausal women: the Japanese population-based osteoporosis study. J Bone Miner Metab 37:53–59CrossRef Tachiki T, Kouda K, Dongmei N, Tamaki J, Iki M, Kitagawa J, Takahira N, Sato Y, Kajita E, Fujita Y, Yura A, Kagamimori S (2019) Muscle strength is associated with bone health independently of muscle mass in postmenopausal women: the Japanese population-based osteoporosis study. J Bone Miner Metab 37:53–59CrossRef
2.
go back to reference Slinker BK, Glantz SA (1985) Multiple regression for physiological data analysis: the problem of multicollinearity. Am J Physiol 249:R1–12CrossRef Slinker BK, Glantz SA (1985) Multiple regression for physiological data analysis: the problem of multicollinearity. Am J Physiol 249:R1–12CrossRef
3.
go back to reference Buckinx F, Landi F, Cesari M, Fielding RA, Visser M et al (2018) Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle 9:269–278CrossRef Buckinx F, Landi F, Cesari M, Fielding RA, Visser M et al (2018) Pitfalls in the measurement of muscle mass: a need for a reference standard. J Cachexia Sarcopenia Muscle 9:269–278CrossRef
4.
go back to reference Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15:95–101CrossRef Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW et al (2014) Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 15:95–101CrossRef
5.
go back to reference Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31CrossRef Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48:16–31CrossRef
Metadata
Title
Response to “Is grip strength an actual/significant predictor of areal bone mineral density by itself? Potential confounders and/or effect modifiers”
Authors
Takahiro Tachiki
Katsuyasu Kouda
Namiraa Dongmei
Junko Tamaki
Masayuki Iki
Jun Kitagawa
Naonobu Takahira
Yuho Sato
Etsuko Kajita
Yuki Fujita
Akiko Yura
Sadanobu Kagamimori
Publication date
01-01-2020
Publisher
Springer Japan
Published in
Journal of Bone and Mineral Metabolism / Issue 1/2020
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-019-01036-6

Other articles of this Issue 1/2020

Journal of Bone and Mineral Metabolism 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine